Richard T Moxley 3rd
Overview
Explore the profile of Richard T Moxley 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1504
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Eichinger K, et al.
Muscle Nerve
. 2015 Jun;
53(2):183-90.
PMID: 26044513
Introduction: The Myotonic Dystrophy Health Index (MDHI) is a disease-specific patient-reported outcome measure. Here, we examine the associations between the MDHI and other measures of disease burden in a cohort...
12.
Gadalla S, Pfeiffer R, Kristinsson S, Bjorkholm M, Hilbert J, Moxley 3rd R, et al.
PLoS One
. 2013 Nov;
8(11):e79851.
PMID: 24236163
Recent studies show that patients with myotonic dystrophy (DM) have an increased risk of specific malignancies, but estimates of absolute cancer risk accounting for competing events are lacking. Using the...
13.
Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, et al.
Ann Neurol
. 2013 Aug;
74(6):862-72.
PMID: 23929620
Objective: To develop RNA splicing biomarkers of disease severity and therapeutic response in myotonic dystrophy type 1 (DM1) and type 2 (DM2). Methods: In a discovery cohort, we used microarrays...
14.
Hilbert J, Ashizawa T, Day J, Luebbe E, Martens W, McDermott M, et al.
J Neurol
. 2013 Jun;
260(10):2497-504.
PMID: 23807151
The onset and symptoms of the myotonic dystrophies are diverse, complicating their diagnoses and limiting a comprehensive approach to their clinical care. This report analyzes the diagnostic delay (time from...
15.
Kalman L, Tarleton J, Hitch M, Hegde M, Hjelm N, Berry-Kravis E, et al.
J Mol Diagn
. 2013 May;
15(4):518-25.
PMID: 23680132
Myotonic dystrophy type 1 (DM1) is caused by expansion of a CTG triplet repeat in the 3' untranslated region of the DMPK gene that encodes a serine-threonine kinase. Patients with...
16.
Johnson N, Luebbe E, Eastwood E, Chin N, Moxley 3rd R, Heatwole C
J Child Neurol
. 2013 Apr;
29(7):983-6.
PMID: 23611887
This study systematically evaluated the symptoms associated with congenital and childhood myotonic dystrophy, and how these symptoms affect health related quality of life. We conducted interviews with patients affected by...
17.
Hilbert J, Johnson N, Moxley 3rd R
J Pediatr
. 2013 Mar;
163(1):12-4.
PMID: 23507025
No abstract available.
18.
Landis S, Amara S, Asadullah K, Austin C, Blumenstein R, Bradley E, et al.
Nature
. 2012 Oct;
490(7419):187-91.
PMID: 23060188
The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and...
19.
Das M, Moxley 3rd R, Hilbert J, Martens W, Letren L, Greene M, et al.
J Neurol
. 2012 May;
259(10):2161-6.
PMID: 22619053
Patients with myotonic dystrophy (DM) have recently been reported to be at increased risk of tumor development, but clinical associations related to this observation are unknown. We calculated the odds...
20.
Gadalla S, Lund M, Pfeiffer R, Gortz S, Mueller C, Moxley 3rd R, et al.
JAMA
. 2011 Dec;
306(22):2480-6.
PMID: 22166607
Context: Myotonic muscular dystrophy (MMD) is an autosomal-dominant multisystem neuromuscular disorder characterized by unstable nucleotide repeat expansions. Case reports have suggested that MMD patients may be at increased risk of...